- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 25th, 2007
The company is engineering nanoscale particles that will deliver two drugs directly to the site of a tumor: One drug will shut down the blood vessels that feed the tumor while the other will deliver chemotherapy over a sustained period. By custom-building the package that will contain these two drugs, Tempo believes it can get the drugs to the right place -- and reduce side effects.
"Nanotechnology," Crane said, "has the potential to redefine drug therapy over the next five to 10 years."
|Related News Press|
European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award: The Award to be presented at BIO-Europe conference in Munich, November 2015 July 30th, 2015
Take a trip through the brain July 30th, 2015
Sol-gel capacitor dielectric offers record-high energy storage July 30th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Shaping the hilly landscapes of a semi-conductor nanoworld August 1st, 2015
Solid state physics: Quantum matter stuck in unrest August 1st, 2015
Self-assembling, biomimetic membranes may aid water filtration August 1st, 2015